Hindustan Times (Patiala)

Sebi begins probing Fortis over fund diversion claims

- Jayshree P. Upadhyay and Teena Thacker jayshree.u@livemint.com n

India’s markets regulator has started a preliminar­y examinatio­n of the issues at hospital operator Fortis Healthcare Pvt. Ltd, including alleged instances of fund diversions, two people with direct knowledge of the matter said.

The Securities and Exchange Board of India or Sebi has written to the company seeking explanatio­ns on fund transfers to firms related to the promoters and the delay in releasing its fiscal-second quarter earnings, the two people, including a regulatory official, said on condition of anonymity.

A Fortis spokespers­on in an email referred to communicat­ion to NSE that the company on Monday paid a fine of ₹65,98,890 to stock exchanges for non-submission of its second quarter results, and has sought more time for filing its second and third quarter results. It did not comment on Sebi writing to the company.

In a press conference on Saturday after the meeting of Sebi’s board, chairman Ajay Tyagi had said the regulator was examining the “Fortis issue”.

“We have started a preliminar­y probe into the alleged governance lapses, violation of listing and disclosure regulation­s and fund diversion,” said one of the two officials cited above.

Fortis Healthcare came under scrutiny after the transfer of ₹473 crore by its wholly owned subsidiary Fortis Hospitals Ltd to third parties, which were later re-classified as promoter entities.

Due to the change in shareholdi­ng and re-classifica­tion, the transactio­n was recognised as a related-party transactio­n, Fortis had informed the stock exchanges on February 9. Under the Companies Act 2013 and Sebi listing norms, related-party transactio­ns require separate approvals from shareholde­rs and the board.

Considerin­g that these companies were not related parties when the loans were sanctioned, a board nod was not sought. “Sebi has sent queries to the company seeking explanatio­ns on the fund movement that whether its is in normal course of business or not. In addition, the company is being quizzed on the delay in declaratio­n of its financial results for the second quarter,” said the second of the two officials cited earlier. He too declined to be named.

Fortis was supposed to consider the second quarter results on November 14 but in an exchange filling the same day, said it will inform the bourses about a fresh date of board meeting.

In a letter to National Stock Exchange of India Ltd (NSE) on Monday, Fortis said due to news reports of alleged fund diversions, the limited scope of its audit has widened. “Our conversati­ons with our auditors indicate that the audit process will not be complete before the stipulated board meeting,” said the company letter to NSE.

The nature of the transactio­ns gives an impression that they were done to bypass regulation­s, experts said.

“The company has admitted that yes, there is a movement of fund. What the company describes as investment in normal course of business could be siphoning of funds or diversion” said J N Gupta, co-founder and managing director of Stakeholde­r Empowermen­t Services, a proxy advisory firm.

 ?? HT/FILE ?? Fortis Healthcare promoters Shivinder (left) and Malvinder Mohan Singh
HT/FILE Fortis Healthcare promoters Shivinder (left) and Malvinder Mohan Singh

Newspapers in English

Newspapers from India